Higher-riskArticle link

Building a Treatment Plan After an Alzheimer's Diagnosis: Medications and Beyond

Receiving an Alzheimer's diagnosis can feel overwhelming, but building a thoughtful treatment plan right away gives you and your loved one a roadmap for the journey ahead. This plan is not just about medications—it's a living document that combines FDA-approved drugs that may slow decline, non-drug strategies like exercise and sleep routines, and practical supports for daily life. While there is no cure yet, early action can help maintain quality of life longer, and you have concrete, evidence-based steps to take now.

Key points

  • A treatment plan should be created soon after diagnosis and include medications, non-drug strategies, and community supports.
  • Anti-amyloid drugs (lecanemab, donanemab) can slow decline modestly but are only for early-stage Alzheimer's and require careful monitoring.
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine are standard for symptom management; start low, go slow, and reassess at 3-6 months.
  • Non-drug strategies like exercise, morning sunlight, sleep hygiene, and behavior journaling are essential and should be tried before medications for sleep or agitation.
  • The plan must be shared with you and documented by your clinician, and reviewed regularly as the disease progresses.
  • Caregiver support is a critical part of the plan—use respite care, support groups, and community resources to prevent burnout.

What a Treatment Plan Is and Why It Matters Now

A treatment plan after an Alzheimer's diagnosis is a coordinated set of actions designed to manage symptoms, slow the progression of the disease, and support both the person with dementia and their caregiver. According to the Alzheimer's Association, the plan should include initial strategies for any neuropsychiatric symptoms (like agitation or delusions) and referrals to community resources such as adult day programs or support groups. This plan must be shared with you and documented by your clinician. The goal is not to cure—because no cure exists—but to promote independence, maintain function, and treat cognitive, behavioral, and psychological symptoms as they arise. Early diagnosis is crucial because it opens the door to treatments that work best in the mild stages, when the brain still has more reserve to preserve.

How Medications Fit Into the Picture

There are two main categories of medications used in Alzheimer's treatment: those that target the underlying biology of the disease (disease-modifying therapies) and those that manage symptoms. The newer anti-amyloid drugs, such as lecanemab and donanemab, are FDA-approved for people in the very earliest stages of Alzheimer's. These drugs reduce amyloid plaques in the brain and have been shown to slow cognitive decline modestly—meaning people on them still decline, but not as quickly as those not taking them. However, they are not a cure, do not work for everyone, and are not appropriate for middle or late stages. The older, more established medications include cholinesterase inhibitors (donepezil, rivastigmine, galantamine) for mild to moderate Alzheimer's, and memantine for moderate to severe stages. These help with memory and thinking symptoms but do not change the underlying disease. For vascular dementia or mixed dementia, cholinesterase inhibitors may still be used if Alzheimer's pathology is present, but they are not FDA-approved for pure vascular cognitive impairment—discuss this with your clinician.

Non-Drug Strategies Are Essential

Medications alone are not enough. Research from the NIH and other sources suggests that lifestyle factors—managing blood pressure, treating hearing loss, taking a daily multivitamin, and engaging in cognitively enriched physical activities like Tai Chi—can support brain health and may reduce dementia risk or slow progression. For sleep changes, non-drug approaches should always be tried first: maintain regular meal and bedtimes, seek morning sunlight, encourage daily exercise (but not within four hours of bedtime), avoid alcohol and caffeine, and create a comfortable, well-lit bedroom. If the person is taking a cholinesterase inhibitor, ask your clinician whether it can be taken in the morning instead of at night. These strategies are especially important because sleep medications can have serious side effects. For behavioral symptoms like sundowning, keeping a journal to identify triggers and using non-drug behavior management techniques (like redirecting, validating feelings, and adjusting the environment) are the first line of defense.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Schedule a comprehensive diagnostic visit with a specialist (neurologist, geriatrician, or memory clinic) to confirm the type and stage of dementia. Use validated tools like the Mini-Cog or Dementia Severity Rating Scale, as recommended by the Alzheimer's Association. Bring a list of all current medications, health conditions, and a journal of symptoms you've observed.

  2. Ask your clinician about disease-modifying therapies (lecanemab or donanemab) if the diagnosis is early-stage Alzheimer's (mild cognitive impairment or mild dementia) and the person is otherwise healthy. These require regular infusions and monitoring for side effects like brain swelling or bleeding—discuss risks and benefits thoroughly.

  3. Discuss starting a cholinesterase inhibitor (donepezil, rivastigmine, or galantamine) for mild to moderate Alzheimer's. The standard approach is 'start low, go slow': begin at a low dose, increase gradually over weeks, and monitor for side effects like nausea, diarrhea, or slow heart rate. Always discuss any changes, including stopping a medication, with your clinician before acting. Reassess cognitive symptoms at 3 and 6 months—if no improvement or significant decline continues, ask your doctor whether it's reasonable to consider stopping.

  4. For moderate to severe Alzheimer's, ask about memantine, which can be used alone or with a cholinesterase inhibitor. Memantine works differently and may help with cognition and function. Again, monitor for side effects and reassess regularly.

  5. Create a daily routine that includes physical activity (like walking for at least 30 minutes most days), cognitive stimulation (puzzles, music, or conversation), and social engagement. Studies suggest that walking, especially when done consistently for two years, may produce cognitive benefits that can last up to seven years later, even for people with the APOE4 risk gene.

  6. Address sleep problems with non-drug strategies first: set consistent wake and bedtimes, expose the person to morning sunlight, avoid caffeine and alcohol after noon, and ensure the bedroom is cool, dark, and quiet. If a cholinesterase inhibitor is taken in the evening, ask the doctor about switching to a morning dose.

  7. Plan for behavioral symptoms like agitation or delusions by keeping a journal to identify triggers (e.g., time of day, hunger, pain, overstimulation). Use non-drug techniques: validate feelings, redirect to a calming activity, reduce noise, and ensure the person is not in pain. Only consider medications (like low-dose antipsychotics) if behaviors are severe and non-drug approaches fail—and always under close medical supervision. If you ever feel unsafe or the behavior becomes dangerous, stop the activity and step away; call for help if needed.

  8. Build a support network: join a caregiver support group, contact your local Alzheimer's Association chapter, and explore adult day programs or respite care. The treatment plan should include referrals to these community resources, as noted by the Alzheimer's Association.

  9. Review the treatment plan with your clinician every 3 to 6 months, or whenever there is a significant change in symptoms or behavior. Adjust medications, non-drug strategies, and support services as needed. Document all discussions in the clinical note.

What not to do

  • Do not wait to start treatment. Early diagnosis is crucial because the most effective medications (like anti-amyloid drugs) are only approved for early stages. Delaying means missing the window for these options. Instead, book an appointment with a specialist as soon as you notice symptoms.

  • Do not expect medications to stop or reverse the disease. They slow decline modestly at best. If you expect a cure, you may feel disappointed and stop all treatments prematurely. Instead, set realistic goals: maintaining function and quality of life for as long as possible.

  • Do not rely solely on medications for sleep or behavioral problems. Sleep medications can cause serious side effects in people with dementia, and antipsychotics carry risks of stroke and death. Always try non-drug strategies first—like adjusting bedtime routines, reducing daytime napping, and identifying triggers.

  • Do not stop or start medications without consulting the doctor. Abruptly stopping a cholinesterase inhibitor can cause a rapid decline. Similarly, starting a new supplement or over-the-counter remedy without medical advice can interact with prescribed drugs. Always discuss changes with the clinician.

  • Do not ignore the caregiver's own health. The treatment plan should include support for you—respite care, counseling, or a support group. If you burn out, the person with dementia suffers too. Make self-care a non-negotiable part of the plan.

Practical tools

  • Symptom and Behavior Journal

    Keep a daily log of the person's mood, sleep, appetite, and any difficult behaviors. Note the time, what happened before (trigger), what you did, and the outcome. This helps you and the clinician identify patterns and decide whether medications are needed. Example entry: '5 PM: Became agitated, pacing. Trigger: loud TV. Redirected to quiet room with music. Calmed after 10 min.'

  • Medication Tracker Chart

    Create a simple chart listing each medication, dose, time given, and any side effects observed. Use a pill organizer with AM/PM slots. Set phone alarms for doses. Bring this chart to every doctor visit. This prevents missed doses and helps track effectiveness.

  • Morning Sunlight Routine

    Expose the person to natural sunlight within 30 minutes of waking. Open curtains, take a short walk, or sit by a window. This helps regulate the sleep-wake cycle and can reduce sundowning. Pair with a simple phrase: 'Let's get some morning sun—it helps us both feel better.'

  • Redirection Script for Agitation

    When the person is upset, use this script: 'I see you're feeling [name emotion]. That's hard. Let's take a break and [offer a simple activity: look at photos, have a snack, listen to music].' Avoid arguing or correcting. Validate their reality first, then redirect. If the person becomes aggressive or you feel unsafe, stop and step away; call for help if needed.

  • Community Resource List

    Compile a one-page list of local resources: Alzheimer's Association chapter, adult day center, home care agencies, support groups, and the local Area Agency on Aging. Keep it by the phone. The treatment plan should include these referrals—ask your clinician for recommendations.

  • Sleep Environment Checklist

    Use this checklist: bedroom temperature 65-68°F, blackout curtains, nightlight in hallway, no TV or screens 1 hour before bed, comfortable mattress, and a consistent bedtime routine (e.g., warm milk, soft music, gentle hand massage). Ask your clinician whether the cholinesterase inhibitor can be taken in the morning instead of at night.

Discuss with your clinician

Ask whether anti-amyloid drugs (lecanemab or donanemab) are appropriate for your loved one's stage and health status, and what the monitoring requirements are.

Discuss the risks and benefits of cholinesterase inhibitors and memantine, including potential side effects like nausea, diarrhea, slow heart rate, or dizziness.

If behavioral symptoms are severe and non-drug approaches have failed, ask about the lowest possible dose of a medication (e.g., an antipsychotic) and the plan for tapering off.

Inquire about clinical trials for new treatments, especially if the person is in early stages and willing to participate.

Ask about the need for an amyloid PET scan or spinal tap to confirm Alzheimer's pathology before starting disease-modifying therapy.

Discuss any supplements or over-the-counter products (like vitamin E, omega-3s, or coconut oil) before starting them—some can interact with medications or have no proven benefit.

Ask your doctor: 'If we decide to stop a cholinesterase inhibitor, how should we do it safely?'

Ask your doctor: 'Can the cholinesterase inhibitor be taken in the morning instead of at night to help with sleep?'

Sources